TBRIF Therma Bright Inc
Therma Bright (TBRIF) Stock Skyrockets After Medicare and Medicaid Milestone, Enters Multi-Billion-Dollar Market
Therma Bright’s stock surges as its Venowave VW5 device secures a crucial Medicare and Medicaid designation, entering the $1.5B DVT market. With a strategic distribution partnership, Therma Bright is poised for rapid growth in medical devices and therapies.
Therma Bright (TBRIF) Stock Skyrockets After Medicare and Medicaid Milestone, Enters Multi-Billion-Dollar Market
Therma Bright’s stock surges as its Venowave VW5 device secures a crucial Medicare and Medicaid designation, entering the $1.5B DVT market. With a strategic distribution partnership, Therma Bright is poised for rapid growth in medical devices and therapies.
Tiny Healthcare Stock With $35 Million Market Cap Becomes Major Player Overnight in Rapidly Growing $1 Billion Market
Therma Bright (TSXV: THRM) secures permanent Medicare and Medicaid reimbursement codes for its Venowave VW5 device, making it the only DVT treatment with such codes. This innovation has driven significant stock gains, with shares rising over 800% since May 2024.